157 related articles for article (PubMed ID: 2198862)
1. [Myasthenia gravis: critical evaluation of the treatment].
De Assis JL
Arq Neuropsiquiatr; 1990 Mar; 48(1):55-70. PubMed ID: 2198862
[TBL] [Abstract][Full Text] [Related]
2. Controversies about the treatment of myasthenia gravis.
Rowland LP
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):644-59. PubMed ID: 7400825
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic considerations in myasthenia gravis].
Vejvalka J
Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
[No Abstract] [Full Text] [Related]
4. [Myasthenia gravis. Treatment].
Somnier FE
Ugeskr Laeger; 1984 Jan; 146(5):345-8. PubMed ID: 6719608
[No Abstract] [Full Text] [Related]
5. Therapeutic options in autoimmune myasthenia gravis.
García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of myasthenia gravis].
Ponseti J; Espín E; Armengol M
Med Clin (Barc); 2000 Sep; 115(7):264-70. PubMed ID: 11013152
[No Abstract] [Full Text] [Related]
7. Management of myasthenia gravis.
Saperstein DS; Barohn RJ
Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis: clinical, immunological, and therapeutic advances.
Romi F; Gilhus NE; Aarli JA
Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
[TBL] [Abstract][Full Text] [Related]
9. [Myasthenia gravis. Recent findings and their therapeutic consequences].
Thümler R; Haferkamp G
Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
[No Abstract] [Full Text] [Related]
10. Therapeutic strategies for myasthenia gravis.
Keys PA; Blume RP
DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
[TBL] [Abstract][Full Text] [Related]
11. [Current therapeutic aspects of myasthenia gravis].
Avilés Mejias S; Ledro Molina D; Garrido Peralta M
Rev Clin Esp; 1981 Oct; 163(2):139-44. PubMed ID: 6276943
[No Abstract] [Full Text] [Related]
12. Mycophenolate mofetil and myasthenia gravis.
Ciafaloni E
Lupus; 2005; 14 Suppl 1():s46-9. PubMed ID: 15803932
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of juvenile myasthenia gravis].
Arroyo HA
Medicina (B Aires); 2019; 79 Suppl 3():71-76. PubMed ID: 31603848
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of myasthenia].
Goulon M; Estournet B; Gajdos P
Rev Prat; 1979 Jun; 29(35):2789-99. PubMed ID: 493836
[No Abstract] [Full Text] [Related]
15. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
[No Abstract] [Full Text] [Related]
16. Myasthenia gravis. Pathogenesis and current concepts in management.
Havard CW; Scadding GK
Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
[TBL] [Abstract][Full Text] [Related]
17. Overview of myasthenia gravis.
Arora Y; Li Y
Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
[TBL] [Abstract][Full Text] [Related]
18. Ocular myasthenia gravis.
Gilbert ME; Savino PJ
Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
[No Abstract] [Full Text] [Related]
19. The treatment of patients with myasthenia gravis.
Sanders DB; Scoppetta C
Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive therapy of myasthenia gravis].
Lechner H; Ott E; Aranibar A
Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
